A medication called cinacalcet an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD) works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN). Cinacalcet is one of a family of drugs called calcimimetics.

More: continued here

This entry was posted on Friday, July 25th, 2008 at 11:07 pm and is filed under Endocrinology. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.